Anacor Pharmaceuticals Inc
Anacor Pharmaceuticals Inc (ANAC) is a publicly traded company in the Unknown sector. Across all available filings, 32 corporate insiders have executed 433 transactions totaling $291.6M, demonstrating a bearish sentiment with -$212.3M in net insider flow. The most recent transaction on Jun 24, 2016 involved a transaction of 68,985 shares valued at $6.8M.
ANAC Insider Activity Summary
Who Is Buying ANAC Stock?
No significant insider buying has been recorded for ANAC in the recent period.
Who Is Selling ANAC Stock?
No significant insider selling has been recorded for ANAC in the recent period.
Is Anacor Pharmaceuticals Inc Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ANAC is bearish with an Insider Alignment Score of 14/100 and a net flow of -$212.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
ANAC Frequently Asked Questions
Understanding ANAC Insider Activity
Insider trading at Anacor Pharmaceuticals Inc (ANAC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 32 insiders are actively trading ANAC stock, having executed 433 transactions in the past 90 days. The most active insider is Anders D. Hove (Executive), who has made 40 transactions totaling $214.9M.
Related Tools
Track Anacor Pharmaceuticals Inc Insider Activity
Get notified when executives and directors at ANAC file new Form 4 transactions